ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Monitoring Brain Activity in Human Brain Injury

This study is not yet open for participant recruitment.
Study NCT00258505.   Last updated on July 31, 2007.   Information provided by Soroka University Medical Center

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Monitoring Brain Activity in Human Brain Injury
Official Title  Incidence, Nature and Consequences of Cortical Depolarizations in Human Brain Injury From Trauma and Ischemia: The COSBID Study
Brief Summary

The outcome of brain injury (physical or stroke) may be related to a brain electrical phenomenon known as Cortical Spreading Depression (CSD). This is a brief cessation of function in a local region of brain tissue. It has been hypothesized that CSD may occur after brain injury and may expand the damage to adjacent brain areas. Our aim is to detect CSD by means of intracranial electrodes in patients with brain injuries and asses how these events alter the outcome of the patients.

Detailed Description

Cortical spreading depression (CSD) is a wave of mass neuronal firing and neuronal and glial depolarisation which propagates through grey matter in the central nervous system in response to a pathologic stimulus, at a rate of between 1 and 5 mm per minute. First described by Leão in 1944 as a sudden depression of ECoG amplitude spreading across the cortex of the rabbit (Leao, A. A. P. 1944), CSD can be elicited in experimental animals by chemical, electrical, and mechanical stimuli, with varying degrees of ease. CSD provoked in healthy, normally perfused neural tissue does not induce persistent metabolic stress or cellular damage, and indeed such induction of CSD in animal experiments may confer protection against the adverse effects of a subsequent ischaemic insult (Kobayashi, S. et al. 1995).

In animal models of focal cerebral ischaemia, usually induced by occlusion of the middle cerebral artery, a spontaneous phenomenon occurs around the periphery of the core territory, with electrophysiological features essentially identical with CSD, and similar capacity to propagate across cerebral cortex. Designated "peri-infarct depolarisation" (PID), this event is associated with infarct expansion, or recruitment of at-risk cortical territory into the expanding core, and has been shown capable of causing this expansion, in the absence of therapeutic intervention. Indeed it has been hypothesized that glutamate release may be involved in PID generation, and that excitotoxicity may accomplish detrimental effects via this route (Hossmann, K. A. 1994), (Obrenovitch, T. P. and Urenjak, J. 1997). Some experimental neuroprotection treatments for stroke act to decrease the incidence of PID (Iijima, T. et al. 1992;Chen, Q. et al. 1993;Busch, E. et al. 1996).

In traumatic and ischaemic (especially in middle cerebral artery occlusion and aneurysmal subarachnoid haemorrhage) brain injury in humans, a phase of delayed deterioration often associated with severe and refractory brain swelling develops between 2 and 5 days after the initial ictus, and is associated with poor or fatal outcome. The cause and mechanism of this deterioration remain poorly understood, and the possibility exists that CSD/PID events might contribute to deterioration.

To date, CSD or PID have been reported in only ten human subjects in two papers (Mayevsky, A. et al. 1996; Strong, A. J. et al. 2002). Strong et al. reported that transient ECoG suppressions suggestive of depolarisations are common - but by no means universal - after brain injury in humans. Sub-dural ECoG electrode strips were placed in 14 patients who had undergone craniotomy for trauma or intracranial hemorrhage; monitoring was for up to 60 h following the injury. Five of these patients (36%) showed patterns of ECoG depression consistent with PID/CSD in brain regions adjacent to the primary injury.

Study Phase
Study Type  Observational
Study Design  Natural History, Longitudinal, Defined Population, Prospective Study
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Traumatic Brain Injury
Aneurysmal Subarachnoid Hemorrhage
Cerebral Infarction
Cerebral Hemorrhage
Intervention  Procedure: Procedure: intracranial monitoring up to 9 days after injury
MEDLINE PMIDs 12468763
Links For List of Participants see http://www.cosbid.org/ This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Not yet recruiting
Enrollment  100
Start Date 
Completion Date September 2007
Eligibility Criteria 

Inclusion Criteria:

Immediately following:

  • traumatic brain injury
  • aneurysmal subarachnoid haemorrhage or
  • spontaneous intracerebral haematoma or
  • stroke involving cerebral cortex

Exclusion Criteria:

  • GCS = 3
  • Bilateral fixed & dilated pupils or other evidence of massive irreversible brain injury
  • more than 5 days post Injury/ictus.
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Anthony Strong, Prof.         Anthony.strong@kcl.ac.uk    
Location Countries  Germany,   Israel
Administrative Information Fields
NCT ID  NCT00258505
Organization ID sor402605ctil
Secondary IDs ††
Study Sponsor  Soroka University Medical Center
Collaborators ††
Investigators 
Principal Investigator:     Alon Friedman, MD/PhD     Soroka University Medical Center    
Principal Investigator:     Jens Dreier, MD     Charite, Berlin, Germany    
Information Provided By Soroka University Medical Center
Verification Date October 2005
First Received Date  November 22, 2005
Last Updated Date July 31, 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers